View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. News
October 13, 2021updated 11 Jul 2022 2:22pm

Veeva introduces new platform for streamlined clinical trial execution

The offering consists of solutions Veeva Vault Clinical Suite, Veeva SiteVault Free and MyVeeva for Patients.

Veeva Systems has introduced the new Veeva Digital Trials Platform, which offers uninterrupted execution of clinical trials and data flow between stakeholders.

Free Case Study
img

Direct-to-Patient Trials: How IRT Plays an Important Role in Bellerophon's Direct-to-Patient Trials

As the industry strengthens its focus on patient centricity, Direct-to-Patient clinical trials have emerged as a popular trial design that have the potential to increase patient recruitment and retention. IRT plays a crucial role in the success of a Direct-to-Patient trial. Because drug supplies are being managed and shipped from distribution facilities directly to patients’ homes, a sponsor must have a high-quality system in place to accurately track the chain of custody, ensure patient-blinding and handle other logistical challenges. What You Will Learn Benefits and challenges associated with the Direct-to-Patient model Bellerophon's top considerations when implementing this trial design How IRT can equip study teams to successfully track chain of custody, ensure patient blinding, and handle logistical challenges
by Suvoda
Enter your details here to receive your free Case Study.

Currently available for early adopters, the platform offers a comprehensive and connected technology ecosystem comprising research sites, patients, and sponsors of trials.

The offering comprises Veeva Vault Clinical Suite, Veeva SiteVault Free, and MyVeeva for Patients.

Clinical operations and clinical data management technology for sponsors and CROs, Vault Clinical Suite is now updated to include Site Connect and eConsent.

Veeva SiteVault Free is an application for sites to modify operations and conduct connected trials with sponsors with the help of Vault Clinical Suite.

A single, intuitive application, MyVeeva for Patients offers an easier pathway for patients to take part in clinical research.

Designed for the specific requirements of patients, sites, and sponsors, all these solutions are integrated facilitating smooth trial execution and data flow.

Sponsors can write and approve a consent form utilising Veeva eConsent. This automatically flows to sites with the help of Veeva SiteVault Free.

Sites can, in turn, update the consent form, get IRB approval and consent participants with the MyVeeva mobile application.

The patient status and consent form has subsequently become available as authorised and reportable data for the sponsor in Vault Clinical Suite.

The company noted that the platform could address the requirements of the life sciences industry for a comprehensive, standardised and integrated solution. It facilities quicker and efficient trials with increased data precision and participant diversity.

Veeva Systems Vault R&D vice-president Jim Reilly said: “By bringing together the growing community of research sites using Veeva SiteVault Free with sponsors using Vault Clinical Suite, we aim to accelerate the move to digital trial execution.

“The Veeva Digital Trials Platform will make clinical trials easier and faster for patients, sites, and sponsors.”

Last month, dermatology company Leo Pharma entered a strategic technology partnership with Veeva Systems for patient-centric digital trials.

Related Companies

Free Case Study
img

Direct-to-Patient Trials: How IRT Plays an Important Role in Bellerophon's Direct-to-Patient Trials

As the industry strengthens its focus on patient centricity, Direct-to-Patient clinical trials have emerged as a popular trial design that have the potential to increase patient recruitment and retention. IRT plays a crucial role in the success of a Direct-to-Patient trial. Because drug supplies are being managed and shipped from distribution facilities directly to patients’ homes, a sponsor must have a high-quality system in place to accurately track the chain of custody, ensure patient-blinding and handle other logistical challenges. What You Will Learn Benefits and challenges associated with the Direct-to-Patient model Bellerophon's top considerations when implementing this trial design How IRT can equip study teams to successfully track chain of custody, ensure patient blinding, and handle logistical challenges
by Suvoda
Enter your details here to receive your free Case Study.

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. Key drug pipeline and competitive landscape changes based on the latest clinical activity, sent every Tuesday. Curated analysis and data-driven insights on clinical trials strategy and operations, sent every Thursday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Clinical Trials Arena